Browse 385 cervical cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 385
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
for
SCC - Squamous Cell Carcinoma, Radiotracer,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18+
Code: NCT07217028
Phase1, Recruiting
Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers
for
Localized Head and Neck Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07225855
Recruiting
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
for
Head and Neck Squamous Cell Carcinoma,
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT07172256
Phase2, Recruiting
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
for
Head and Neck Squamous Cell Carcinoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: All
Age: 18+
Code: NCT05031910
Recruiting
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
for
Squamous Cell Carcinoma of Head and Neck
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT07455032
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma
for
Stage II Squamous Cell Carcinoma of the Head and Neck,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06161545
Phase2, Recruiting
Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers
for
Head and Neck Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06985784
Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Damariscotta ME, Bath ME, Augusta ME, Brunswick ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase3, Recruiting
Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
for
Cutaneous Squamous Cell Carcinoma of the Head and Neck,
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06990737
Phase2, Recruiting
Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07465276
Phase2, Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: South Portland ME, Boston MA, New Haven CT,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase3, Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
for
Neoplasms, Head and Neck
Location: Worcester MA, Farmington CT, New Haven CT, The Bronx NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06256588
Phase3, Recruiting
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
for
Head and Neck Squamous Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06162377
Recruiting
Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 19+
Code: NCT05901545
Phase1, Recruiting
Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 19+
Code: NCT05945875
Phase1, Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, New Haven CT, New Brunswick NJ, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase1, Phase2, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Montreal, Fairfax VA, Durham NC, Toronto,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
for
Endometrial Cancer, Cervical Cancer
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT06538337
Recruiting
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
for
Cervix Cancer, Cervical Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: Female
Age: 18+
Code: NCT06266338
Phase2, Recruiting
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy